{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:38:09Z","timestamp":1761813489899,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.wneu.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T12:30:12Z","timestamp":1550925012000},"page":"383-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dasatinib Reinitiation After Poststroke Thrombolysis Associated with Symptomatic Intracerebral Hemorrhage"],"prefix":"10.1016","volume":"125","author":[{"given":"Robert A.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mausaminben","family":"Hathidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Dania","family":"Shujaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6254-2313","authenticated-orcid":false,"given":"Bradley N.","family":"Bohnstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-0920","authenticated-orcid":false,"given":"Bappaditya","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2019.02.026_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40265-016-0677-x","article-title":"Dasatinib: a review in chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.wneu.2019.02.026_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1517\/17425255.2012.652615","article-title":"Pharmacokinetics of alteplase in the treatment of ischaemic stroke","volume":"8","author":"Acheampong","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.wneu.2019.02.026_bib3","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2019.02.026_bib4","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2009-02-205328","article-title":"The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in\u00a0vitro and in\u00a0vivo","volume":"114","author":"Gratacap","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2019.02.026_bib5","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.02.026_bib6","first-page":"1","article-title":"Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia","author":"Mezei","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.wneu.2019.02.026_bib7","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.31357","article-title":"Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"124","author":"Naqvi","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2019.02.026_bib8","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/cncr.31232","article-title":"Dasatinib dose management for the treatment of chronic myeloid leukemia","volume":"124","author":"Talpaz","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2019.02.026_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood-2008-09-180604","article-title":"Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia","volume":"114","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2019.02.026_bib10","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2174\/1381612822666160226132630","article-title":"Targeting kinases in cancer therapies: adverse effects on blood platelets","volume":"22","author":"Levade","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.wneu.2019.02.026_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1593\/tlo.09280","article-title":"Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib","volume":"3","author":"Kast","year":"2010","journal-title":"Transl Oncol"},{"key":"10.1016\/j.wneu.2019.02.026_bib12","doi-asserted-by":"crossref","first-page":"36661","DOI":"10.1074\/jbc.M301253200","article-title":"Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase","volume":"278","author":"Avraham","year":"2003","journal-title":"J\u00a0Biol Chem"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019304371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019304371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:33:10Z","timestamp":1761813190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019304371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":12,"alternative-id":["S1878875019304371"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.02.026","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dasatinib Reinitiation After Poststroke Thrombolysis Associated with Symptomatic Intracerebral Hemorrhage","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}